Concepedia

Kozo Oka

KO

6

Publications

169

Citations

6

H-Index

1999

Active since

Affiliations

Mitsubishi Tanabe Pharma Corporation(Current)

Mitsubishi Group (Japan)

Tanabe Research Laboratories

Teikoku Seiyaku (Japan)

Kozo Oka is an author at Mitsubishi Tanabe Pharma Corporation specializing in medicine, health sciences, and metabolism.

Top concepts

Publications per year

1999–2023

6

Publications

6

Antioxidants Suppress Plasma Levels of Lectinlike Oxidized Low-Density Lipoprotein Receptor-Ligands and Reduce Atherosclerosis in Watanabe Heritable Hyperlipidemic Rabbits

Kozo Oka, M. Yasuhara, Kuniharu Suzumura et al. · Journal of Cardiovascular Pharmacology · 2006 · 53 citations

Longitudinal characterization of diet-induced genetic murine models of nonalcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients

Naomichi Abe, Sayuka Kato, Takuma Tsuchida et al. · Biology Open · 2019 · 33 citations · Full text

Protection by a cyclic AMP-specific phosphodiesterase inhibitor, rolipram, and dibutyryl cyclic AMP against Propionibacterium acnes and lipopolysaccharide-induced mouse hepatitis

Ioe Taguchi, Kozo Oka, Kazuyuki Kitamura et al. · Inflammation Research · 1999 · 28 citations

, , +7

The effect of combined treatment with canagliflozin and teneligliptin on glucose intolerance in Zucker diabetic fatty rats

Takahiro Oguma, Chiaki Kuriyama, Keiko Nakayama et al. · Journal of Pharmacological Sciences · 2015 · 26 citations · Full text

A monoclonal antibody activating AdipoR for type 2 diabetes and nonalcoholic steatohepatitis

Naomi Asahara, Miki Okada‐Iwabu, Masato Iwabu et al. · Science Advances · 2023 · 15 citations · Full text

Rows per page

1–5 of 6